Le Lézard

VivoSim to Debut Antibody Drug Conjugate Data, representing a major new market for NAMkind models, at Society of Toxicology Meeting in San Diego

VivoSim Labs, Inc. (the "Company" or "VivoSim"), a provider of next-generation New Approach Methodologies (NAMs) for preclinical safety, today announced it will attend the Society of Toxicology ("SOT" ...

Researchers develop a new model to study colorectal cancer

Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed ...
The Lancet

Pharmacotherapy for metabolic dysfunction-associated steatohepatitis: heart–liver co-management

Metabolic dysfunction-associated steatotic liver disease (MASLD) affects approximately 30% of adults, with about 30% of cases progressing to metabolic dysfunction-associated steatohepatitis (MASH), ...
News-Medical.Net on MSN

New genetic model reveals role of keratin 8 in colorectal cancer development

Researchers at Åbo Akademi University have identified a new molecular change in patients with colorectal cancer and developed a genetic disease model that forms tumors in the large intestine, ...
Gut

Rise of prediagnostic molecular profiling in inflammatory bowel disease—can we close the door before the horse has bolted?

Inflammatory bowel disease (IBD) is typically diagnosed after the onset of symptoms in the context of established, characteristic patterns of intestinal inflammation. However, there is now substantial ...